Noven CEO Is Former President of Pfizer’s U.S. Pharma Operations Brandt
Executive Summary
Presidents & CEOs
You may also be interested in...
Pfizer’s Brandt to retire
U.S. President of Pharmaceutical Operations Peter Brandt will retire from Pfizer after 28 years with the company; his position has been eliminated under the restructuring of the U.S. pharmaceutical division. Brandt, a prominent member of Pfizer's management in recent years, previously served as senior VP-global pharmaceutical finance prior to organizational changes implemented by CEO Jeffrey Kindler in August (1"The Pink Sheet" Aug. 21, 2006, p. 3)...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials